| RS1794873824 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1794873983 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1794878769 |
TSPAN12
|
Health Risk |
Pathogenic |
— |
| RS1794879475 |
CUX1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1794880739 |
ELN
|
Health Risk |
Pathogenic |
Williams syndrome, Williams syndrome |
| RS179489 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Congenital long QT syndrome |
| RS1794916576 |
CNTNAP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1794918929 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1794924933 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS1794951633 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1795015022 |
POT1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Tumor predisposition syndrome 3 |
| RS1795029901 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1795069423 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1795110728 |
AASS
|
Health Risk |
Pathogenic |
Hyperlysinemia, Hyperlysinemia |
| RS1795183662 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1795205877 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1795220933 |
ELN
|
Health Risk |
Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1795316019 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1795316757 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1795353084 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1795356111 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1795413179 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1795430058 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1795435288 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1795437460 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1795441247 |
MMP21
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1795515981 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1795518054 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS1795541254 |
CCM2
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1795596096 |
C19orf12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 4, Hereditary spastic paraplegia 43 |
| RS1795637153 |
TRAF3IP2
|
Health Risk |
Pathogenic |
Candidiasis, familial |
| RS1795644961 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1795645080 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1795652293 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1795654181 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tumor predisposition syndrome 3 |
| RS1795752214 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS1795765698 |
PCLO
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1795851272 |
POT1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1795852638 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1795853533 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1795856406 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1795923815 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1795936426 |
TRIO
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1796033726 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome type 6, Joubert syndrome 17 |
| RS1796054104 |
AP4M1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS1796061500 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1796087833 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1796090545 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS1796107143 |
TRAF3IP2
|
Health Risk |
Pathogenic |
Candidiasis, familial |
| RS1796176171 |
AP4M1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1796247872 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1796279189 |
AP4M1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS1796355377 |
EYA4
|
Health Risk |
Pathogenic |
— |
| RS1796390308 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1796390355 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1796390486 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1796391959 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1796406634 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1796431541 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1796448992 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1796449608 |
CPA1
|
Health Risk |
Likely pathogenic |
— |
| RS1796506869 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1796511665 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1796511689 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS1796575397 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1796678879 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1796684525 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1796684604 |
CD36
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 10, Platelet-type bleeding disorder 10 |
| RS1796703260 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1796729286 |
PDE8B
|
Health Risk |
Likely pathogenic |
— |
| RS1796899754 |
KMT2E
|
Health Risk |
Likely pathogenic |
O'Donnell-Luria-Rodan syndrome, O'Donnell-Luria-Rodan syndrome |
| RS1796939367 |
KEL
|
Health Risk |
Pathogenic |
Kell blood group system, Kell blood group system |
| RS1796956272 |
CEP41
|
Health Risk |
Likely pathogenic |
Joubert syndrome 15, Joubert syndrome 15 |
| RS1797012961 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1797063858 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1797182637 |
SLC4A2
|
Health Risk |
Pathogenic |
Osteopetrosis, autosomal recessive 9 |
| RS1797218441 |
ELN
|
Health Risk |
Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1797225811 |
ELN
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 1 |
| RS1797324598 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1797327591 |
CCM2
|
Health Risk |
Likely pathogenic |
Cerebral cavernous angioma, Subcutaneous venous lacunae |
| RS1797356889 |
CEP41
|
Health Risk |
Likely pathogenic |
Joubert syndrome 15, Joubert syndrome 15 |
| RS1797490749 |
CNTNAP2
|
Health Risk |
Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1797560612 |
AGK
|
Health Risk |
Pathogenic |
Sengers syndrome, Cataract 38 |
| RS1797572218 |
KMT2E
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1797574932 |
KMT2E
|
Health Risk |
Likely pathogenic |
O'Donnell-Luria-Rodan syndrome, O'Donnell-Luria-Rodan syndrome |
| RS1797607693 |
GIMAP5
|
Health Risk |
Pathogenic/Likely pathogenic |
Portal hypertension, noncirrhotic |
| RS1797714974 |
CEP41
|
Health Risk |
Pathogenic |
Joubert syndrome 15, Joubert syndrome 15 |
| RS1797725670 |
MDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1797769314 |
KMT2E
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1797770708 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1797772026 |
RP1L1
|
Health Risk |
Likely pathogenic |
Occult macular dystrophy, Occult macular dystrophy |
| RS1797825562 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Occult macular dystrophy |
| RS1797840556 |
RP1L1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1797868307 |
RP1L1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1797899160 |
RP1L1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 88, Retinitis pigmentosa 88 |
| RS1797910388 |
RP1L1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1797913431 |
CD36
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 10, Platelet-type bleeding disorder 10 |
| RS1797973431 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1797999551 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1798067945 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |